Health Alzheimer's Disease study plans to study 2,000 volunteers' brain scans and blood work to identify biomarkers of ...

Within Tibetan medicine, the medicinal herb Terminalia chebula (T. chebula) is well-known for its extensive therapeutic ...

Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s ...

Rensselaer Polytechnic Institute (RPI) has been awarded two grants by the National Institute on Aging (NIA) to train graduate ...

Researchers intrigued by people with hallmarks of Alzheimer’s disease — but none of the symptoms — have probed their brains in the search for a cure. They initially drew samples from the Netherlands ...

A new study distinguishes between two distinct phases of Alzheimer's disease: an early, 'stealth' one without symptoms, and a ...

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a ...

MALVERN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- via IBN – Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage ...

Sage is lopping off one-third of its workforce after one of its experimental drugs failed to prove effective as a treatment ...

The annual Walk to End Alzheimer's will take place on Saturday, November 2 ... Hogner said the event aims to raise awareness, ...

Utilising genetic information responsibly allows people to understand the uncertain waters of Alzheimer's with both knowledge and hope; ready to confront challenges together. Here’s why genetic testin ...

A new Macquarie University study suggests that instead of relying on the 'bible' of mental health diagnosis, we need a ...